UiPath Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy

70

PATH
UiPath

Last Price:

12.63

Seasonality Move:

13.58%

Sell

47

RARE
Ultragenyx Pharmaceutical

Last Price:

54.85

Seasonality Move:

12.42%

Buy

70

UiPath (PATH) is a Buy

Is UiPath a Buy, Sell or Hold?

The current UiPath [PATH] share price is $12.64. The Score for PATH is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
PATH is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

47

Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

The current Ultragenyx Pharmaceutical [RARE] share price is $54.79. The Score for RARE is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PATH Stock Price Chart

What is UiPath's stock price today?

The UiPath share price today is $12.64
The current trend is moderately bearish and PATH is experiencing selling pressure, which indicates risk of future bearish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

The Ultragenyx Pharmaceutical share price today is $54.79
The current trend is moderately bearish and RARE is experiencing slight buying pressure.

PATH Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.13	Buy
Relative Strength Index (14 RSI):	50.85	Buy
Chaikin Money Flow:	-4973160	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(12.3 - 12.86)	Buy
Bollinger Bands (100):	(11.7 - 12.74)	Buy

RARE Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.03	Buy
Relative Strength Index (14 RSI):	47.17	Sell
Chaikin Money Flow:	157903	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(53.97 - 57.61)	Sell
Bollinger Bands (100):	(42.49 - 56.25)	Buy

PATH Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	12.8	Sell
20-day SMA:	12.61	Buy
50-day SMA:	12.41	Buy
200-day SMA:	17.1	Sell
8-day EMA:	12.77	Sell
20-day EMA:	12.63	Buy
50-day EMA:	12.6	Buy
200-day EMA:	15.26	Sell

RARE Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	55.68	Sell
20-day SMA:	55.18	Sell
50-day SMA:	55.69	Sell
200-day SMA:	47.54	Buy
8-day EMA:	55.4	Sell
20-day EMA:	55.43	Sell
50-day EMA:	54.18	Buy
200-day EMA:	48.46	Buy

UiPath Earnings Growth & PATH Earnings Dates

Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.08 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.05 per share, and an increase next year of $1.10 per share.

UiPath Technical Analysis

	Oct 8	Oct 9	Oct 10	Oct 11	Oct 14	Oct 15	Oct 16	Oct 18	Oct 21	Oct 22
	Oct
	08	09	10	11	14	15	16	18	21	22
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

	Oct 8	Oct 9	Oct 10	Oct 11	Oct 14	Oct 15	Oct 16	Oct 18	Oct 21	Oct 22
	Oct
	08	09	10	11	14	15	16	18	21	22
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):